Objective:To develop a nomogram model for predicting the risk of medication deviation in ischemic stroke patients after hospital discharge, providing insights for clinical nursing strategies.Methods:A convenience sampling method was used to select 440 ischemic stroke patients hospitalized in the Neurology Department of Nanyang Central Hospital from March 2022 to September 2023. Data on basic patient information and post-discharge medication deviation were collected using the medication deviation assessment tool eight weeks after discharge. Patients were categorized into a no medication deviation group and a medication deviation group. Univariate and binomial logistic regression analyses were conducted to identify independent risk factors for post-discharge medication deviation, and a nomogram prediction model was developed.Results:Data were successfully collected from 424 patients, with a response rate of 96.36% (424/440). The incidence of medication deviation was 58.02% (246/424). Binomial logistic regression analysis identified the absence of a fixed caregiver ( OR=2.113, P=0.001), large number of comorbid chronic diseases ( OR=1.773, P<0.001), medication non-adherence ( OR=2.443, P=0.003), and negative coping ( OR=2.255, P<0.001) as independent risk factors for medication deviation. A nomogram prediction model based on these four risk factors was constructed. The Hosmer-Lemeshow goodness-of-fit test indicated good calibration (χ 2=10.569, P=0.227), with calibration curve closely approximating the ideal line. The area under the receiver operating characteristic curve was 0.770 (95% CI: 0.584-0.866) . Conclusions:The absence of a fixed caregiver, medication non-adherence, negative coping, and large number of comorbid chronic diseases are independent risk factors for medication deviation in ischemic stroke patients. The nomogram model developed in this study demonstrates good discrimination and accuracy, providing a basis for formulating targeted nursing strategies.

Objective:To develop a nomogram model for predicting the risk of medication deviation in ischemic stroke patients after hospital discharge, providing insights for clinical nursing strategies.Methods:A convenience sampling method was used to select 440 ischemic stroke patients hospitalized in the Neurology Department of Nanyang Central Hospital from March 2022 to September 2023. Data on basic patient information and post-discharge medication deviation were collected using the medication deviation assessment tool eight weeks after discharge. Patients were categorized into a no medication deviation group and a medication deviation group. Univariate and binomial logistic regression analyses were conducted to identify independent risk factors for post-discharge medication deviation, and a nomogram prediction model was developed.Results:Data were successfully collected from 424 patients, with a response rate of 96.36% (424/440). The incidence of medication deviation was 58.02% (246/424). Binomial logistic regression analysis identified the absence of a fixed caregiver ( OR=2.113, P=0.001), large number of comorbid chronic diseases ( OR=1.773, P<0.001), medication non-adherence ( OR=2.443, P=0.003), and negative coping ( OR=2.255, P<0.001) as independent risk factors for medication deviation. A nomogram prediction model based on these four risk factors was constructed. The Hosmer-Lemeshow goodness-of-fit test indicated good calibration (χ 2=10.569, P=0.227), with calibration curve closely approximating the ideal line. The area under the receiver operating characteristic curve was 0.770 (95% CI: 0.584-0.866) . Conclusions:The absence of a fixed caregiver, medication non-adherence, negative coping, and large number of comorbid chronic diseases are independent risk factors for medication deviation in ischemic stroke patients. The nomogram model developed in this study demonstrates good discrimination and accuracy, providing a basis for formulating targeted nursing strategies.

Objective:To investigate the effect of intranasal oxytocin administration on empathy in male adolescents with conduct disorder.Methods:The male adolescents with conduct disorder in the Psychological Counseling Clinic of the Second Xiangya Hospital of Central South University from September 2015 to August 2016 were selected.And they were randomly assigned to oxytocin group ( n=46) and placebo group ( n=51) by random number table. Subjects in oxytocin group were given nasal spray of 24 IU oxytocin twice per day for two weeks, while those in placebo group were given nasal spray of 0.9% sodium chloride solution for two weeks. The empathy of patients was assessed with a pain-related empathy task and interpersonal reactivity index (IRI) before and after two weeks′ administration. SPSS 20.0 software was used for statistical analysis, and repeated measurement analysis of variance was used to compare the empathy ability of the two groups before and after intervention. Results:Repeated measurement analysis of variance showed that there were significant time×group interaction effects in the scores of painful expressions during the pain-related empathy task ( F=13.86, P<0.001), IRI ( F=5.59, P=0.020) and empathic concern subscale ( F=4.99, P=0.028). There was significant between-group effect in the score of perspective-taking subscale of IRI( F=4.22, P=0.043). Simple effect analysis revealed that after two weeks of intervention, the score of needle-pain expression in oxytocin group was significantly higher than that at baseline ( t=-2.08, P=0.040). And the score of needle-pain expression in oxytocin group was significantly higher than that in placebo group ( t=2.33, P=0.022). After two weeks of intervention, the total IRI score ( t=-2.58, P=0.011) and empathy factor score ( t=-3.15, P=0.002) of oxytocin group were both higher than those at baseline. After intervention, the total IRI score ( t=2.30, P=0.024) and perspective-taking factor score ( t=2.57, P=0.012) in oxytocin group were higher than those in placebo group, and the differences were statistically significant. Conclusions:Oxytocin may improve the cognitive and emotional empathy in male adolescents with conduct disorder.

Objective:To investigate the impact of Notch signaling pathway on the migration of human hepatic carcinoma cells and the expression of E-cadherin and COX-2 in these cells.Methods:Cultured hepatic carcinoma cell lines (SMMC-7721,MHCC97H),and normal non tumor liver cell line (HL-7702) in vitro.Transwell cell was used to measure the cell's capacity of invasion and migration.Western blot was used to measure the expression level ofNotch1,E-cadherin,COX-2 protein.DAPT was used to block the Notch signaling pathway,and compared the ability of invasion and migration between hepatic carcinoma cell lines and normal non tumor liver cell line,and the change of expression level of E-cadherin and COX-2 protein in hepatic carcinoma cells.Results:The migration ability of SMMC-7721 cells and MHCC97H cells were higher than HL-7702 cells,the difference was statistically significant (P＜0.05);Compared to HL-7702 cells,the expression level of Notch1 and COX-2 in MHCC97H cells and SMMC-7721 cells significantly increased,the expression level of E-cadherin decreased significantly (P＜0.05);After DAPT treatment,the migration ability of SMMC-7721 cells,MHCC97H cells were weaker than the control group,the difference was statistically significant (P＜0.05);After DAPT treatment,the expression of COX-2 and Notch1 in SMMC-7721 and MHCC97H cells decreased significantly,while the expression of E-cadherin significantly increased (P＜0.05).Conclusion:Notch signaling pathway plays an important role in the process of liver cancer cell migration and invasion,and its mechanism is related to the expression of E-cadherin and COX-2.

Liver transplantation,the most effective therapeutic way to the treatment of end-stage hepatopathy,has been widely used in clinical practice,but the complication,ischemic type biliary lesions has been considered the crucial factor influencing the long-term survival and quality of life of patient.In this article,we review the mechanism and the progressions of biliary lesions induced by liver I/R in recent years.

Objective To investigate the clinical characteristics and the treatment of pancreatic encephalopathy (PE) and Wernicke's encephalopathy (WE). Method A retrospective study was conducted on 596 cases of acute pancreatitis. Results There were 93 cases of severe acute pancreatitis (SAP),among them encephalopathy was discovered in 10 patients (1.7%). All 6 patients of PE developed in SAP (6.5%);3 patients died (3% of SAP,50% of PE). Four cases of WE developed in AP (0.7%);2 patients died (0.3% of AP,50% of WE). Two patients of WE were treated with parenteral thiamine (vitamin B_ 1 ),and they survived. Conclusions PE occurred in early stage of SAP or recrudescence,while WE usually occurred in convalescent stage of SAP/AP. Long fasting,repeated vomiting,and total parenteral nutrition (TPN) without VitB_ 1 were main causes of VitB_ 1 deficiency,which might be the main causative factor in WE.